search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
NEWS


Private equity firm to acquire Univar Solutions for $8.1 billion


US chemical and ingredients distributor Univar Solutions is to be acquired by New York private equity firm Apollo Global for $8.1 billion.


The deal, expected to close


in the second half of the year, will see Abu Dhabi Investment Authority take a minority stake in Illinois-based Univar Solutions. The agreement will result in


Univar Solutions shareholders receiving $36.15 per share in cash, which represents a 20.6% premium to the closing stock price on 22 November 2022. Upon completion of the


transaction, shares of Univar Solutions common stock will no longer trade on the New York


Stock Exchange, and Univar Solutions will become a privately held outfit. The company will continue


to operate under the Univar Solutions name and brand and maintain a global presence. “Over the last three years, we


have transformed the company, putting the customer at the centre of all we do, which has solidified our position as a leading value-added service and solution provider. This transaction reflects the success of our strategy and delivers substantial value to our shareholders,” said David Jukes, president and chief executive officer of Univar Solutions. “In Apollo, we are pleased


to gain a partner to support continued investment in our portfolio and I look forward to working closely with their team as we grow Univar Solutions and serve our key suppliers and customers globally,” he added. Apollo private equity partner


Sam Feinstein said: “In recent years, David and his team have


made tremendous progress enhancing the customer experience, and we believe Univar can accelerate its long-term strategy as an Apollo portfolio company. “We look forward to leveraging


our extensive experience in the sector to support management in this exciting next phase.”


L’Oréal invests in biotech ingredient maker Genomatica


L’Oréal has invested in Genomatica, a US developer of biotechnology-based alternatives to critical ingredients in cosmetic formulations. As a result of the investment,


Genomatica will deploy its proven biotechnology platform, using proprietary engineered microorganisms to ferment plant sugars that produce ingredients to make sustainable surfactants. These new ingredients will be used in a range of L’Oréal’s products, marking an essential step towards L’Oréal’s goals of 100% eco-designed formulas that respect the diversity of aquatic


ecosystems and 95% of ingredients from renewable plant-based sources or abundant minerals by 2030. L’Oréal joins Unilever and Kao


in investing in San Diego-based Genomatica. Financial details of the transaction were not disclosed. “Welcoming L’Oréal to this


incredible team of global brand heavyweights signifies just how important and urgent the need is for traceable, resilient and sustainable materials, at scale,” said Genomatica chief executive Christophe Schilling. “This partnership will further


catapult our venture’s mission to the global scale required to meet strong


acquire Australian luxury beauty brand Aesop for $2.525 billion. Aesop currently operates


around 400 points of sale across the Americas, Europe, Australia, New Zealand, and Asia, with a nascent footprint in China where the first store opened in 2022. Created in 1987, Aesop sells


market demand for sustainable products,” he added. In a related development,


L’Oréal has entered into an agreement with Natura & Co to


skin, hair and body products with plant-based ingredients and sustainable vegan formulations in signature amber packaging. The brand posted sales of $537m in 2022. The acquisition is subject to certain regulatory approvals and other customary conditions.


KLK Oleo acquires Italian esters maker Temix Oleo


KLK Oleo has entered into a definitive agreement to acquire a controlling stake in Temix Oleo, an Italian manufacturer of esters. Headquartered in Milan, Temix


Oleo has a production plant in Calderara di Reno (Bologna) and employs around 100 people, with a turnover of €150m ($158m) in 2022. Temix Oleo’s esters are mainly


based on renewable feedstocks, and the company supplies the cosmetic, lubricant, ceramic, coating,


www.personalcaremagazine.com


closing conditions. KLK Oleo is the manufacturing


division of KLK, a leading international plantations group listed on the Malaysia stock exchange with a market capitalisation of approximately €4.8 billion as of September 2022. “Temix Oleo outstanding


rubber and plastics industries. The transaction is expected to


be completed by April, subject to regulatory approval and customary


reputation is built on their customer- centric and high-quality service business model. We are excited to welcome the Temix Oleo team and


their excellent product portfolio to be part of the group of KLK,” said Sriganesh Mathur Subramanian, Managing Director, KLK Emmerich. Temix Oleo managing director


Roberto Cella added: “This acquisition is an opportunity for Temix Oleo to continue to grow, in product portfolio and geographic areas, with focus on sustainability and innovation. Being part of the KLK Group, employees can look forward to a bright future.”


May 2023 PERSONAL CARE


9


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119